Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.
- Aged 18-21
- Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases.
- Able to provide written informed consent and willing to comply with study procedures.
- Can read either English or Spanish.
- Willing to be contacted in the future by study staff.
- Scientific Research
- Time commitment TBD
- Rochester, Minnesota
This Gig not right for you?
Not to worry! We've got more paid opportunities on the way.
Sign up so you are the first to hear!
(Already have an account - then you're all set!)